September 18, 2015 - This Advanced Training Statement addresses the added competencies required of subsubspecialists in CCEP for diagnosis and management of patients with cardiac arrhythmias and conduction disturbances at a high level of skill. It is intended to complement the basic training in cardiac electrophysiology (EP) required of all trainees during the standard 3-year cardiovascular fellowship.
Search for "" returned 101 matches
September 23, 2015 - Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health.
August 1, 2012 — The expert consensus statement provides recommendations for the practical management of CRT patients before, during and after the implantation procedure. The statement does not discuss clinical indications for CRT therapy as these are covered by other guidelines statements.
2007 Addendum to Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness1378
February 7, 2007 — This addendum to a 1996 advisory addresses driving restrictions in patients who receive an Implantable Cardioverter Defibrillator (ICD) for primary prevention.
2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion1279
October 2006 — Developed in collaboration With the Heart Rhythm Society, this competence statement was designed to assist in the assessment of physicians' competence on a procedure-specific basis. The update specifies the minimum education, training, experience, and cognitive and technical skills necessary for the competent performance of invasive cardiac electrophysiology, catheter ablation, and cardioversion.
December 10, 2015 - The evolution of LAA occlusion technology has spanned nearly two decades and three FDA panel hearings, leading to FDA approval in 2015. As this technology becomes clinically available to a broader population of patients, it is essential that physician stakeholders establish criteria for the performance of these procedures that will be used in granting initial and ongoing privileges. These criteria are offered to support The Joint Commission mandate that medical staff privileges be granted on the basis of professional criteria specified in the medical staff bylaws to ensure safe and effective patient-centered care.
2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing24544
November 19, 2015 - The benefits and risks of ICD therapy for patients are directly impacted by the programming and surgical decisions made by the clinician. This expert consensus statement systemically describes four important clinical issues and addresses programming of: bradycardia mode and rate, tachycardia detection, tachycardia therapy, and intraprocedural testing of defibrillation efficacy.
February 1, 2015 - The Heart Rhythm Society convened a forum of stakeholders in medical device innovation in conjunction with the 2015 Heart Rhythm Society Annual Scientific Sessions. The forum facilitated open discussion on medical device innovation, including obstacles to physician involvement and possible solutions. This report is based on the themes that emerged.
2009 — The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association, the Heart Failure Association, and the Heart Rhythm Society. This is a revised version of the 2004 ESC Guidelines on Syncope.
August 15, 2006 — A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines
This document has been retired and replaced by "2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation."